FRX Fennec Pharmaceuticals Inc.

13.48USD19.29 CAD · TSX+0.63%Mkt Cap: 476.07M USDP/E: 482.25

Fennec Pharmaceuticals Inc. operates as a commercial stage biopharmaceutical company in the United States. The company's product candidate includes PEDMARK, a formulation of sodium thiosulfate for the prevention of cispl…